In the rapidly evolving field of biochemical research, the study of protein-protein interactions has opened new doors for understanding cellular signaling. My journey into this niche began with a fascination for the Hippo pathway and its regulatory components. Among the various compounds I have encountered, Peptide 17 stands out as a signifi YAP–TEAD interaction (IC50=25 nM).YAP-TEAD-IN-1 is a 17mer peptideand shows a higher the binding affinity to TEAD1 (Kd=15 nM) than YAP (50-171) (Kd=40 nM).Read more cant subject of study, particularly regarding its role as a YAP-TEAD protein-protein interaction inhibitor.
Understanding the Mechanism of Peptide 17
When analyzing Peptide 17, it is essential to recognize its structural classification. It is a 17mer peptide designed to modulate the by M Fan·2022·Cited by 65—For example, a cyclicYAP-likepeptidehas been developed as a potent disruptor ofYAP-TEAD complex in cell lysates but failed to exert effects Read more Hippo signaling pathway. In my review of the existing literature, I found it fascinating that Peptide 17 exhibits a binding affinity to TEAD1 (Kd = 15 nM) that is notably stronger than that of the native YAP (50-171) fragment (Kd = 40 nM). This high affinity makes it a precise tool for researchers looking to investigate the complex dynamics of YAP-TEAD-IN-1, which is a 17mer peptide frequently utilized in laboratory settings.
From my personal perspective, the specificity of these inhibitors is what makes them so valuable. Whether one is looking at YAP-TEAD Inhibitor 1 (Peptide 17) for cellular assays or exploring its biochemical properti YAP-TEAD Inhibitor 1 (Peptide 17) is a YAP-TEAD protein-protein interaction inhibitor which has potential usage in treatment of YAP-involved cancers with IC50 Read more es, the precision afforded by an IC50 of 25 nM allows for highly controlled experimental environments.
Research Context and Applications
The discourse YAP - Stem Cell - Signaling Pathways surrounding Peptide 17 often touches upon its potential in various research models. One of the most compelling areas of study involves how Peptide 17 alleviat Peptide 17 alleviates early hypertensive renal injury by es early renal injury in hypertension. By regulating the Hippo/YAP signaling pathway, this compound provides a unique lens through which scientists can observe cellular responses to stress.
Furthermore, YAP and TAZ are TEAD coactivators (1, 17, 18) that play a pivotal role in maintaining cellular homeostasis. Because YAP1/TAZ signaling is crucial for cancer and wound healing, m Structure-Based Design and Synthesis of Potent Cyclic - PMC any researchers focus on how a YAP peptide can interfere with these pathways to inhibit unwanted proliferation. It is important to note that Peptide 17 is a inhibitor of this YAP-TEAD protein-protein interaction, and while some newer variants like YTP-17 is an orally active YAP-TEAD protein-protein interaction inhibitor are emerging, the original Peptide 17 remains a foundational reference point in molecular biology labs.
Observations on Quality and Efficacy
When sourcing high-purity reagents like Peptide 17, consistency is key. My experience indicates that the YAP-TEAD-IN-1 TFA is a 17mer peptide that requires careful handling to maintain its structural integrity. In my observations, the potency of the inhibitor is directly linked to the purity of the synthetic product. Researchers often compare this to other emerging molecules, such as those discussed in the broader context of best peptide for kidney repair or peptides for kidney repair, though Peptide 17 remains distinct due to its specific target.
Final Thoughts
The study of the Hippo pathway remains one of the most intelle by M Fan·2022·Cited by 65—For example, a cyclicYAP-likepeptidehas been developed as a potent disruptor ofYAP-TEAD complex in cell lysates but failed to exert effects Read more ctually stimulating areas of modern research. Whether you are investigating the nuances of Yap signaling or comparing different inhibitors, the data surrounding peptide 17 provides a robust framework for scientific inquiry. It is a testament to the power of structure-based design that a specific 17mer peptide can serve as such a potent interruptor of complex protein associations.
For those engaging in this field, staying updated on the latest citations regarding YAP-TEAD Inhibitor 1 (Peptide 17) is vital. As we continue to refine our understanding of these signaling cascades, the role of specialized inhibitors will undoubtedly become even more significant in uncovering the mysteries of signal transduction.